Journal of Neural Transmission

, 113:1909

Effect of cabergoline added to levodopa treatment on sleep-wake cycle in idiopathic Parkinson’s disease: an open label 24-hour polysomnographic study

  • A. Romigi
  • P. Stanzione
  • M. G. Marciani
  • F. Izzi
  • F. Placidi
  • A. Cervellino
  • P. Giacomini
  • L. Brusa
  • K. Grossi
  • M. Pierantozzi
Article

Summary.

Few studies focused on the effects of cabergoline on sleep-wake cycle in PD. Twelve patients affected by PD treated with levodopa as monotherapy underwent two 24-hour ambulatory polysomnographic (A-PSG) sessions twice: in baseline condition (levodopa as monotherapy) and after addition of cabergoline. In each condition, a subjective evaluation of sleep quality and daytime sleepiness was obtained by means of Parkinson’s disease Sleep Scale (PDSS) and the Epworth Sleepiness Scale. The statistical analysis of sleep parameters revealed a significant increase of sleep efficiency and slow wave sleep under cabergoline. The PDSS total score showed a significant improvement of overall sleep quality after cabergoline. No significant changes in daytime sleepiness were observed. No patient referred and/or showed sleep attacks before and after addition of cabergoline. We hypothesize that the long-lasting effect of cabergoline may improve the objective quality of nocturnal sleep in PD patients complaining nocturnal motor disability without inducing daytime sleepiness.

Keywords: Parkinson’s disease, sleep, excessive daytime somnolence, cabergoline, polysomnography, Parkinson’s disease Sleep Scale, Epworth Sleepiness Scale 

References

  1. Arnulf, I, Konofal, E, Merino-Andreu, M, Houeto, JL, Mesnage, V, Welter, ML, Lacomblez, L, Golmard, JL, Derenne, JP, Agid, Y 2002Parkinson’s disease and sleepiness: an integral part of PDNeurology5810191024PubMedGoogle Scholar
  2. Askenasy, JJ 1993Sleep in Parkinson’s diseaseActa Neurologica Scan87167170CrossRefGoogle Scholar
  3. Baas, HKJ, Schueler, P 2001Efficacy of cabergoline in long term use: results of three observational studies in 1500 patients with Parkinson’s diseaseEur Neurol461823PubMedCrossRefGoogle Scholar
  4. Carskadon, MA, Dement, WC 1992Multiple sleep latency tests during the constant routineSleep15396399PubMedGoogle Scholar
  5. Chaudhuri, KR, Pal, S, Bridgman, K, Trenkwalder, C 2001Achieving 24-hour control of Parkinson’s disease symptoms: use of objective measures to improve nocturnal disabilityEur Neurol46310PubMedCrossRefGoogle Scholar
  6. Chaudhuri, KR, Pal, S, DiMarco, A, Whately-Smith, C, Bridgman, K, Mathew, R, Pezzela, FR, Forbes, A, Hogl, AB, Trenkwalder, C 2002aThe Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s diseaseJ Neurol Neurosurg Psychiatry73629635CrossRefGoogle Scholar
  7. Chaudhuri, KR, Pal, S, Brefel-Courbon, C 2002b‘Sleep attacks’ or ‘unintended sleep episodes’ occur whit dopamine agonists: is this a class effect?Drug Saf25473483CrossRefGoogle Scholar
  8. Chaudhuri, KR, Martinez-Martin, P 2004Clinical assessment of nocturnal disability in Parkinson’s disease: the Parkinson’s disease Sleep ScaleNeurology63S17S20PubMedGoogle Scholar
  9. Coleman, RM, Pollak, CP, Weitzman, ED 1980Periodic movements in sleep (nocturnal myoclonus): relation to sleep disorderAnn Neurol8416421PubMedCrossRefGoogle Scholar
  10. Del Dotto, P, Gambaccini, G, Caneparo, D, Berti, C, Bernardini, S, Bonuccelli, U 2003Bedtime cabergoline in Parkinson’s disease patients with excessive daytime sleepiness induced by dopamine agonistsNeurol Sci24170171PubMedCrossRefGoogle Scholar
  11. Factor, SA, McAlarney, T, Snachez-Ramos, JR, Weiner, WJ 1990Sleep disorders and sleep effect in Parkinson’s diseaseMov disord5280285PubMedCrossRefGoogle Scholar
  12. Fahn S, Elton RL, Members of the UPDRS development committee (1997) Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M (eds) Recent development in Parkinson’s disease, Vol. 2 MacMillan Healthcare Information: Florham Park, NY, pp 153–163, 293–304Google Scholar
  13. Fariello, RG 1998Pharmacodynamic and pharmacokinetic features of cabergoline. Rationale for use in Parkinson’s diseaseDrugs551016PubMedCrossRefGoogle Scholar
  14. Ferreira, JJ, Galitzky, M, Montastruc, JL, Rascol, O 2000Sleep attacks and Parkinson’s disease treatmentLancet35513331334PubMedCrossRefGoogle Scholar
  15. Frucht, S, Rogers, JD, Greene, PE, Gordon, MF, Fahn, S 1999Falling asleep at the wheel: motor vehicle mishaps in person taking pramipexole and ropirinoleNeurology5219081910PubMedGoogle Scholar
  16. Garcia-Borreguero, D, Schwarz, C, Larrosa, O, de la Llave, Y, Garcia de Yebenes, J 2003L-DOPA-induced excessive daytime somnolence in PD: a placebo-controlled case with MSLT assessmentNeurology6110081010PubMedGoogle Scholar
  17. Gigli, GL, Placidi, F, Diomedi, M, Maschio, M, Silvestri, G, Scalise, A, Marciani, MG 1996Sleep in healthy elderly subjects: a 24-hour polysomnographic studyInt J Neurosci85263271PubMedGoogle Scholar
  18. Goetz, CG, Blasucci, L, Stebbins, GT 1999Switching dopamine agonists in advanced Parkinson’s disease: is rapid titration preferable to slow?Neurology5212271229PubMedGoogle Scholar
  19. Grosset, K, Needleman, F, Macphee, G, Grosset, D 2004Switching from ergot to nonergot dopamine agonists in Parkinson’s disease: a clinical series and five-drug dose conversion tableMov Disord Nov19370374Google Scholar
  20. Hogl, B, Rothdach, A, Wetter, TC, Trenkwalder, C 2003The effect of cabergoline on sleep, periodic leg movements in sleep, and early morning motor function in patients with Parkinson’s dieseaseNeuropsychopharmacology2818661870PubMedCrossRefGoogle Scholar
  21. Homann, CN, Wenzel, K, Suppan, K, Ivanic, G, Kriechbaum, N, Crevenna, R, Ott, E 2002Sleep attacks in patient taking dopamine agonists: reviewBMJ32414831487PubMedCrossRefGoogle Scholar
  22. Johns, MW 1991A new method for measuring daytime sleepiness: the Epworth sleepiness scaleSleep14540545PubMedGoogle Scholar
  23. Lang, AE, Hobson, DE, Martin, W, Rivest, J 2001Excessive daytime somnolence and sudden onset sleep in Parkinson’s disease: a survey from 18 Canadian movement disorders clinicsNeurology56A212A213Google Scholar
  24. Lera, G, Vaamonde, J, Rodriguez, M, Obeso, JA 1993Cabergoline in Parkinson’s disease: long term follow-upNeurology4325872590PubMedGoogle Scholar
  25. Nausieda, PA, Weiner, WJ, Kaplan, LR, Weber, S, Klawans, HL 1982Sleep disruption in the course of chronic levodopa therapy: an early feature of the levodopa psychosisClin Neuropharmacol5183194PubMedGoogle Scholar
  26. Olanow, CW, Schapira, AH, Roth, T 2000Waking up to sleep episodes in Parkinson’s diseaseMov Disord15212215PubMedCrossRefGoogle Scholar
  27. Ondo, WG, Dat Vuong, K, Khan, H, Atassi, F, Kwak, C, Jankovic, J 2001Daytime sleepiness and other sleep disorders in Parkinson’s diseaseNeurology5713921396PubMedGoogle Scholar
  28. Pal, S, Bhattacharya, KF, Agapito, C, Chaudhuri, KR 2001A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson’s disease patients taking pramipexole cabergoline and levodopa mono and combination therapyJ Neural Transm1087177PubMedCrossRefGoogle Scholar
  29. Paus, S, Brecht, HM, Koster, J, Seeger, G, Klockgether, T, Wullner, U 2003Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson’s diseaseMov Disord18659667PubMedCrossRefGoogle Scholar
  30. Poewe, W, Hogl, B 2000Parkinson’s disease and sleepCurr Opin Neurol13423426PubMedCrossRefGoogle Scholar
  31. Rechtshafen A, Kales A (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Los Angeles: UCLA Brain Information Service/Brain Research InstituteGoogle Scholar
  32. Romigi, A, Brusa, L, Marciani, MG, Pierantozzi, M, Placidi, F, Izzi, F, Sperli, F, Testa, F, Stanzione, P 2005Sleep episodes and daytime somnolence as result of individual susceptibility to different dopaminergic drugs in a PD patient: a polysomnographic studyJ Neurol Sci228710PubMedCrossRefGoogle Scholar
  33. Romigi, A, Marciani, MG, Placidi, F 2004L-dopa-induced excessive daytime somnolence in PD. A placebo-controlled case with MSLT assessmentNeurology621454PubMedGoogle Scholar
  34. Rye, DB, Jankovic, J 2002Emerging views of dopamine in modulation sleep/wake state from unlike source: PDNeurology58341346PubMedGoogle Scholar
  35. Tan, EK, Lum, SY, Fook-Chong, SM, Teoh, ML, Yih, Y, Tan, L, Tan, A, Wong, MC 2002Evaluation of somnolence in Parkinson’s disease: comparison with age- and sex-matched controlsNeurology58465468PubMedGoogle Scholar
  36. Tandberg, E, Larsen, JP, Karlsen, K 1998A community-based study of sleep disorders in patients with Parkinson’diseaseMov Disord13895899PubMedCrossRefGoogle Scholar
  37. Ulivelli, M, Rossi, S, Lombardi, C, Bartalini, S, Rocchi, R, Giannini, F, Passero, S, Battistini, N, Lugaresi, E 2002Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PDNeurology58462465PubMedGoogle Scholar
  38. van Hilten, JJ, Weggeman, M, van der velde, EA, Kerkhof, GA, van Dijk, JG, Roos, RA 1993Sleep, excessive daytime sleepiness and fatigue in Parkinson’s diseaseJ Neural Transm5235244CrossRefGoogle Scholar
  39. Wetter, TC, Collado-Seidel, V, Pollmacher, T, Yassouridi, SA, Trenkwalder, C 2000Sleep and periodic leg movement pattern in drug-free patient with Parkinson’s disease and multiple system atrophySleep23361367PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • A. Romigi
    • 1
    • 3
  • P. Stanzione
    • 2
    • 3
  • M. G. Marciani
    • 1
    • 3
  • F. Izzi
    • 2
  • F. Placidi
    • 1
    • 3
  • A. Cervellino
    • 1
  • P. Giacomini
    • 4
  • L. Brusa
    • 2
  • K. Grossi
    • 1
  • M. Pierantozzi
    • 1
    • 3
  1. 1.University of Rome “Tor Vergata” Policlinico Tor Vergata Servizio di Neurofisiopatologia Centro di Medicina del SonnoRomeItaly
  2. 2.University of Rome “Tor Vergata” Dipartimento di Neuroscienze Clinica NeurologicaRomeItaly
  3. 3.IRCCS Fondazione Santa LuciaRomeItaly
  4. 4.Università di Roma La Sapienza, Clinica NeurologicaRomeItaly

Personalised recommendations